DelveInsight's Chronic Hepatitis D Market Insights report includes a comprehensive understanding of current treatment ...

Boehringer Ingelheim exercises option to license additional Dark Antigens from a wider array of tumor types, expanding Enara’s eligibility for ...

Since it was first detected in the U.S. in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds ...

CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

Apex Legends Season 9 delivered one of its most emotionally charged lore drops with the Legacy Antigen comic, and this video ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells. The modality has remained a big draw for Big Pharma, with Eli Lilly penning ...

Detailed price information for Marker Therapeutics Inc (MRKR-Q) from The Globe and Mail including charting and trades.

The next major drugmaker interested in what Repertoire has to offer is Eli Lilly, which has thrown down $85 million upfront and floated up to $1.84 billion more in biobucks to collaborate on potential ...

One of the changes that the U.S. Department of Health and Human Services recently made to the childhood immunization schedule ...

Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against ...

Gronkowski joins Super Bowl-winning head coach Bruce Arians in the playful commercial that carries a serious message.